I'rom Group Co

I'rom Group Co EBITDA

Delisted

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of I'rom Group Co (2372.T) as of Oct 19, 2026 is 1.13 B JPY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 3.64 B JPY — a change of -68.84% (lower).

EBITDA

1.13 BJPY

YoY

-68.84%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of I'rom Group Co is 2024 1.13 B JPY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of I'rom Group Co was 2023 3.64 B JPY. It decreases by -68.84% lower compared to the previous year.

The I'rom Group Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2017
212.00 M JPY
Jan 1, 2018
1.04 B JPY
Jan 1, 2019
1.22 B JPY
Jan 1, 2020
1.21 B JPY
Jan 1, 2021
1.07 B JPY
Jan 1, 2022
2.76 B JPY
Jan 1, 2023
3.64 B JPY
Jan 1, 2024
1.13 B JPY
The I'rom Group Co EBITDA history
YEAREBITDAYoY
1.13 BJPY-68.84%
3.64 BJPY+31.66%
2.76 BJPY+158.80%
1.07 BJPY-11.52%
1.21 BJPY-0.98%
1.22 BJPY+16.76%
1.04 BJPY+392.45%
212.00 MJPY-144.17%
-480.00 MJPY-37.82%
-772.00 MJPY+92.04%
-402.00 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

I'rom Group Co Stock analysis

What does I'rom Group Co do? I'rom Group Co. Ltd is a Japanese company specialized in medical services. It was founded in April 2007 and is headquartered in Tokyo, Japan. The company has become a significant player in the medical service sector in Japan within a few years. Its business model focuses on medical services and the sale of medical products, specifically in the areas of Life-Science and Clinical Research. I'rom offers support in clinical studies, distributes medications and medical devices, and provides CRM services. The company is divided into different divisions that offer various specialized products and services such as clinical research services, medical development services, corporate staffing services, and CRM services. I'rom also offers a wide range of medical products, mainly targeting the Japanese market. In conclusion, I'rom Group Co. Ltd is a leading company in the field of medical services in Japan, providing integrated support in product development and marketing for the life science and healthcare industries. I'rom Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about I'rom Group Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of I'rom Group Co is 1.13 B JPY in 2024.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of I'rom Group Co changed from 3.64 B JPY to 1.13 B JPY, representing a -68.84% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) I'rom Group Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s I'rom Group Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — I'rom Group Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — I'rom Group Co